|
|
盆腔淋巴瘤1例病例报告及文献复习
|
Abstract:
分析盆腔弥漫性大B细胞淋巴瘤的诊治要点。通过对一例盆腔弥漫性大B细胞淋巴瘤患者的病例进行详尽的回顾性研究，并复习了相关文献。该病例为女性，74岁，初期症状为绝经后阴道出血，经活检病理诊断为弥漫性大B细胞淋巴瘤，治疗方案包括前三个周期泼尼松(POLA-R-CDP)，维泊妥珠单抗联合利妥昔单抗，多柔比星和环磷酰胺。接下来的第4~6周期，患者接受了环磷酰胺，长春新碱(R-CHOP)，利妥昔单抗，阿霉素的化疗方案，第7周期的治疗为利妥昔单抗联合大剂量甲氨蝶呤(HDMTX)。在第8周期，患者接受了阿糖胞苷、鞘内注射地塞米松和甲氨蝶呤。目前，患者的病灶已显著减小，且未观察到复发迹象。盆腔淋巴瘤是一种罕见的疾病，通常表现为无特异性在临床上，治疗方面现推荐6~8轮R-CHOP + 放疗(45 Gy) (Radiotherapy, RT) ± 手术治疗，对于高度怀疑该病的病例应尽早明确诊断，治疗方式的选择至关重要。
To investigate the diagnosis and treatment of pelvic diffuse large B-cell lymphoma. A case of pelvic diffuse large B-cell lymphoma was analyzed retrospectively and the literature was reviewed. The patient, a 74-year-old female, presented with postmenopausal vaginal bleeding as the initial symptom and was diagnosed with diffuse large B-cell lymphoma by biopsy and pathology. She received the chemotherapy regimen of Vepostuzumab combined with rituximab, cyclophosphamide, doxorubicin, and prednisone (POLA-R-CDP) at the first 1~3 cycles. Chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine (R-CHOP) regimen at cycle 4~6, rituximab combined with high-dose methotrexate (HDMTX) at cycle 7, intravaginal injection of dexamethasone, cytarabine, and methotrexate at cycle 8, the patient’s lesions were significantly smaller than before, and no signs of recurrence were observed. Pelvic lymphoma is an extremely rare disease with non-specific clinical manifestations, and 6~8 rounds of R-CHOP + Radiotherapy (45 Gy) (Radiotherapy, RT) plus surgery are now recommended for treatment. For highly suspected cases, the diagnosis should be made as early as possible, and the choice of treatment mode is crucial.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
| [2] | Vannata, B. and Zucca, E. (2015) Primary Extranodal B-Cell Lymphoma: Current Concepts and Treatment Strategies. Chinese Clinical Oncology, 4, Article No. 10. |
| [3] | Nasioudis, D., Kampaktsis, P.N., Frey, M., Witkin, S.S. and Holcomb, K. (2017) Primary Lymphoma of the Female Genital Tract: An Analysis of 697 Cases. Gynecologic Oncology, 145, 305-309. https://doi.org/10.1016/j.ygyno.2017.02.043 |
| [4] | Bowzyk Al-Naeeb, A., Ajithkumar, T., Behan, S. and Hodson, D.J. (2018) Non-Hodgkin Lymphoma. British Medical Journal, 362, k3204. https://doi.org/10.1136/bmj.k3204 |
| [5] | Armitage, J.O., Gascoyne, R.D., Lunning, M.A. and Cavalli, F. (2017) Non-Hodgkin Lymphoma. The Lancet, 390, 298-310. https://doi.org/10.1016/s0140-6736(16)32407-2 |
| [6] | Yu, J., Zhang, J. and Su, X.T. (2019) Expression and Clinical Significance of Serum LRG1 in Patients with Diffuse Large B-Cell Lymphoma before Treatment. Journal of Experimental Hematology, 27, 1850-1855. |
| [7] | Capsa, C., Calustian, L.A., Antoniu, S.A., Bratucu, E., Simion, L. and Prunoiu, V. (2022) Primary Non-Hodgkin Uterine Lymphoma of the Cervix: A Literature Review. Medicina, 58, Article 106. https://doi.org/10.3390/medicina58010106 |
| [8] | Shi, S., Li, W., Ni, G., Ding, J., Liu, Y., Wu, H., et al. (2024) Primary Lymphoma of the Female Genital Tract Masquerading as Gynecological Malignancy. BMC Women’s Health, 24, Article No. 247. https://doi.org/10.1186/s12905-024-03037-8 |
| [9] | Wu, J., Tian, T., Huang, Y., Liang, J., Miao, Y., Wang, L., et al. (2016) Serum Carbohydrate Antigen 125 Concentration as a Superior Predictor for Serosal Effusion at Diagnosis and a Prognostic Factor in Diffuse Large B-Cell Lymphoma. Cancer Biomarkers, 17, 205-212. https://doi.org/10.3233/cbm-160632 |
| [10] | Mohammed, T.J., Gosain, R., Sharma, R. and Torka, P. (2019) Lactic Acidosis: A Unique Presentation of Diffuse Large B-Cell Lymphoma. BMJ Case Reports, 12, e230277. https://doi.org/10.1136/bcr-2019-230277 |
| [11] | Pfahler, V., D’Anastasi, M., Dürr, H., Schinner, R., Ricke, J. and Baur-Melnyk, A. (2020) Tumor Load in Patients with Multiple Myeloma: β₂-Microglobulin Levels versus Low-Dose Whole-Body CT. European Journal of Haematology, 104, 383-389. https://doi.org/10.1111/ejh.13356 |
| [12] | 刘爱宁, 李媛媛, 刘婷婷. 弥漫大B细胞淋巴瘤患者血清肿瘤负荷相关指标与临床分期、治疗效果及临床预后的关系[J]. 疑难病杂志, 2020, 19(11): 1119-1124. |
| [13] | Salem, U., Menias, C.O., Shaaban, A., Bhosale, P.R., Youssef, A. and Elsayes, K.M. (2014) Hematopoietic Tumors of the Female Genital System: Imaging Features with Pathologic Correlation. Abdominal Imaging, 39, 922-934. https://doi.org/10.1007/s00261-014-0102-4 |
| [14] | Živković, K., Marton, I., Tikvica Luetić, A., Gašparov, S., Horvat Pavlov, K., Sović, L., et al. (2021) Torquated Large Ovarian Lymphoma as a Cause of Acute Abdomen: A Case Report of Diffuse Large B-Cell Ovarian Lymphoma with a Germinal Center B-Cell-Like Phenotype. Wiener Medizinische Wochenschrift, 172, 181-183. https://doi.org/10.1007/s10354-021-00823-z |
| [15] | Cheng, H., Tang, X. and Cheng, J. (2017) Pathologic Character and Diagnosis of Female Primary Genital System Diffuse Large B Cell Lymphoma. European Review for Medical and Pharmacological Sciences, 21, 1471-1476. |
| [16] | Tilly, H., Gomes da Silva, M., Vitolo, U., Jack, A., Meignan, M., Lopez-Guillermo, A., et al. (2015) Diffuse Large B-Cell Lymphoma (DLBCL): ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 26, v116-v125. https://doi.org/10.1093/annonc/mdv304 |
| [17] | Lagoo, A.S. and Robboy, S.J. (2006) Lymphoma of the Female Genital Tract: Current Status. International Journal of Gynecological Pathology, 25, 1-21. https://doi.org/10.1097/01.pgp.0000183049.30212.f9 |
| [18] | Rathore, R., Arora, V.K. and Singh, B. (2016) Lymphoepithelioma-Like Carcinoma of Cervix. Diagnostic Cytopathology, 45, 239-242. https://doi.org/10.1002/dc.23629 |
| [19] | Yang, G., Deisch, J., Tavares, M., Haixia, Q., Cobb, C. and Raza, A.S. (2016) Primary B-Cell Lymphoma of the Uterine Cervix: Presentation in Pap-Test Slide and Cervical Biopsy. Diagnostic Cytopathology, 45, 235-238. https://doi.org/10.1002/dc.23627 |
| [20] | Fox, H., Langley, F.A., Govan, A.D.T., Hill, A.S. and Bennett, M.H. (1988) Malignant Lymphoma Presenting as an Ovarian Tumour: A Clinicopathological Analysis of 34 Cases. International Journal of Obstetrics & Gynaecology, 95, 386-390. https://doi.org/10.1111/j.1471-0528.1988.tb06611.x |
| [21] | Dorth, J.A., Prosnitz, L.R., Broadwater, G., Beaven, A.W. and Kelsey, C.R. (2012) Radiotherapy Dose-Response Analysis for Diffuse Large B-Cell Lymphoma with a Complete Response to Chemotherapy. Radiation Oncology, 7, Article 100. https://doi.org/10.1186/1748-717x-7-100 |
| [22] | 中华人民共和国国家卫生健康委员会. 淋巴瘤诊疗指南(2022年版) [J]. 中国肿瘤临床与康复, 2023, 30(3):135-158. |
| [23] | Goda, J.S., Gaikwad, U., Narayan, A., Kurkure, D., Yadav, S., Khanna, N., et al. (2020) Primary Diffuse Large B Cell Lymphoma of Uterine Cervix: Treatment Outcomes of a Rare Entity with Literature Review. Cancer Reports, 3, e1264. https://doi.org/10.1002/cnr2.1264 |
| [24] | Iizuka, N., Ikura, Y., Fukuoka, Y., Shibata, T., Okamoto, M., Kamiya, A., et al. (2020) Malignant Lymphoma of the Ovary: A Diagnostic Pitfall of Intraoperative Consultation. International Journal of Gynecological Pathology, 39, 79-83. https://doi.org/10.1097/pgp.0000000000000571 |
| [25] | Stabile, G., Ripepi, C., Sancin, L., Restaino, S., Mangino, F.P., Nappi, L., et al. (2023) Management of Primary Uterine Cervix B-Cell Lymphoma Stage IE and Fertility Sparing Outcome: A Systematic Review of the Literature. Cancers, 15, Article 3679. https://doi.org/10.3390/cancers15143679 |
| [26] | Wilkie, G.L., Taggart, A.A., Prensner, J.R., Billett, A.L. and Laufer, M.R. (2019) Burkitt Lymphoma Presenting as Menorrhagia and a Vaginal Mass in an Adolescent. Journal of Pediatric and Adolescent Gynecology, 32, 90-92. https://doi.org/10.1016/j.jpag.2018.09.009 |
| [27] | Gisselbrecht, C., Schmitz, N., Mounier, N., Singh Gill, D., Linch, D.C., Trneny, M., et al. (2012) Rituximab Maintenance Therapy after Autologous Stem-Cell Transplantation in Patients with Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma. Journal of Clinical Oncology, 30, 4462-4469. https://doi.org/10.1200/jco.2012.41.9416 |
| [28] | Li, S., Young, K.H. and Medeiros, L.J. (2018) Diffuse Large B-Cell Lymphoma. Pathology, 50, 74-87. https://doi.org/10.1016/j.pathol.2017.09.006 |
| [29] | El-Galaly, T.C., Cheah, C.Y., Hutchings, M., Mikhaeel, N.G., Savage, K.J., Sehn, L.H., et al. (2016) Uterine, but Not Ovarian, Female Reproductive Organ Involvement at Presentation by Diffuse Large B-Cell Lymphoma Is Associated with Poor Outcomes and a High Frequency of Secondary CNS Involvement. British Journal of Haematology, 175, 876-883. https://doi.org/10.1111/bjh.14325 |
| [30] | Cao, X., Li, J., Zhang, W., Duan, M., Shen, T. and Zhou, D. (2014) Patients with Primary Diffuse Large B-Cell Lymphoma of Female Genital Tract Have High Risk of Central Nervous System Relapse. Annals of Hematology, 93, 1001-1005. https://doi.org/10.1007/s00277-013-2003-y |
| [31] | Schmitz, N., Zeynalova, S., Nickelsen, M., Kansara, R., Villa, D., Sehn, L.H., et al. (2016) CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chop. Journal of Clinical Oncology, 34, 3150-3156. https://doi.org/10.1200/jco.2015.65.6520 |
